Besides FAM84A, ALKBH5 was reported to regulate alternative CSC targets, such as FOXM128,56, TACC334, and NANOG29, implying that multiple ALKBH5 downstream targets might collaterally contribute to stemness in CRC. Here, LRATD1 is linked to colorectal carcinoma.